The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122977393 12297739 3 F 201307 20160630 20160422 20160707 EXP US-ABBVIE-16K-163-1610326-00 ABBVIE 55.22 YR M Y 92.62000 KG 20160707 CN COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122977393 12297739 1 PS HUMIRA ADALIMUMAB 1 Subcutaneous LOADING DOSE 1053312 125057 160 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
122977393 12297739 2 SS HUMIRA ADALIMUMAB 1 Subcutaneous TWO WEEKS AFTER 160 MG DOSE 1053312 125057 80 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
122977393 12297739 3 SS HUMIRA ADALIMUMAB 1 Subcutaneous FOUR WEEKS AFTER 160 MG DOSE 1053312 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN QOW
122977393 12297739 4 SS HUMIRA ADALIMUMAB 1 Subcutaneous FOUR WEEKS AFTER 160 MG DOSE 1053312 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN QOW
122977393 12297739 5 SS SYNTHROID LEVOTHYROXINE SODIUM 1 Oral Y UNKNOWN 21402 125 UG TABLET QD
122977393 12297739 6 SS SYNTHROID LEVOTHYROXINE SODIUM 1 Oral TOOK ONE HALF TAB Y UNKNOWN 21402 62.5 UG TABLET QD
122977393 12297739 7 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 0
122977393 12297739 8 C ATENOLOL. ATENOLOL 1 0
122977393 12297739 9 C AMLODIPINE AMLODIPINE BESYLATE 1 0
122977393 12297739 10 C IMURAN AZATHIOPRINE 1 0
122977393 12297739 11 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 0
122977393 12297739 12 C TEMAZEPAM. TEMAZEPAM 1 0
122977393 12297739 13 C TRAMADOL. TRAMADOL 1 0
122977393 12297739 14 C HYOSCYAMINE. HYOSCYAMINE 1 0
122977393 12297739 15 C DICYCLOMINE DICYCLOMINE HYDROCHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122977393 12297739 1 Crohn's disease
122977393 12297739 5 Hypothyroidism
122977393 12297739 7 Blood cholesterol increased
122977393 12297739 8 Hypertension
122977393 12297739 9 Hypertension
122977393 12297739 10 Crohn's disease
122977393 12297739 11 Nausea
122977393 12297739 12 Insomnia
122977393 12297739 13 Product used for unknown indication
122977393 12297739 14 Abdominal pain
122977393 12297739 15 Abdominal pain

Outcome of event

Event ID CASEID OUTC COD
122977393 12297739 HO
122977393 12297739 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122977393 12297739 Abdominal pain
122977393 12297739 Blood thyroid stimulating hormone increased
122977393 12297739 Dysuria
122977393 12297739 Faecaloma
122977393 12297739 Feeling abnormal
122977393 12297739 Hernia
122977393 12297739 Incorrect dose administered
122977393 12297739 Intestinal stenosis
122977393 12297739 Pain in extremity
122977393 12297739 Postoperative adhesion
122977393 12297739 Rectal discharge

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122977393 12297739 1 20130411 20130411 0
122977393 12297739 2 2013 2013 0
122977393 12297739 3 2013 201307 0
122977393 12297739 4 2013 0
122977393 12297739 5 201604 0
122977393 12297739 6 201604 0
122977393 12297739 7 201412 0